These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21922303)

  • 1. The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model.
    Qiu P; Li Y; Ding Y; Weng J; Banks SM; Kern S; Fitz Y; Suffredini AF; Eichacker PQ; Cui X
    Intensive Care Med; 2011 Oct; 37(10):1688-95. PubMed ID: 21922303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.
    Remick DG; Call DR; Ebong SJ; Newcomb DE; Nybom P; Nemzek JA; Bolgos GE
    Crit Care Med; 2001 Mar; 29(3):473-81. PubMed ID: 11373406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factor.
    Smith EF; Slivjak MJ; Egan JW; Gagnon R; Arleth AJ; Esser KM
    Pharmacology; 1993 May; 46(5):254-67. PubMed ID: 8488170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Giercksky KE
    Crit Care Med; 1995 Aug; 23(8):1382-90. PubMed ID: 7634809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of soluble tumour necrosis factor alpha receptors during and after paediatric cardiopulmonary bypass. Correlation with haemodynamic and clinical variables.
    Saatvedt K; Lindberg H; Michelsen S; Pedersen T; Seem E; Geiran O
    Cytokine; 1996 Dec; 8(12):944-8. PubMed ID: 9050754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
    van Deuren M; Frieling JT; van der Ven-Jongekrijg J; Neeleman C; Russel FG; van Lier HJ; Bartelink AK; van der Meer JW
    Clin Infect Dis; 1998 Apr; 26(4):918-23. PubMed ID: 9564476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model.
    Cui X; Parent C; Macarthur H; Ochs SD; Gerstenberg E; Solomon S; Fitz Y; Danner RL; Banks SM; Natanson C; Salvemini D; Eichacker PQ
    J Appl Physiol (1985); 2004 Oct; 97(4):1349-57. PubMed ID: 15169752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental therapies for sepsis directed against tumour necrosis factor.
    Read RC
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():65-9. PubMed ID: 9511088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model.
    Sherer K; Li Y; Cui X; Li X; Subramanian M; Laird MW; Moayeri M; Leppla SH; Fitz Y; Su J; Eichacker PQ
    Crit Care Med; 2007 Jun; 35(6):1560-7. PubMed ID: 17452924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo administration of endotoxin and tumor necrosis factor-alpha produce different effects on constitutive and inducible nitric oxide synthase activity in rat neutrophils and aorta ex vivo.
    Greenberg SS; Xie J; Joseph KO; Kolls J; Summer W
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):199-208. PubMed ID: 7530365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty.
    Krasinski K; Spyridopoulos I; Kearney M; Losordo DW
    Circulation; 2001 Oct; 104(15):1754-6. PubMed ID: 11591609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats.
    Li Y; Li X; Haley M; Fitz Y; Gerstenberger E; Banks SM; Eichacker PQ; Cui X
    Intensive Care Med; 2006 Aug; 32(8):1263-70. PubMed ID: 16775718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-antibiotic treatment of sepsis].
    Møller K; Kronborg G; Pedersen BK
    Ugeskr Laeger; 2000 May; 162(20):2872-5. PubMed ID: 10860425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
    Karzai W; Cui X; Mehlhorn B; Straube E; Hartung T; Gerstenberger E; Banks SM; Natanson C; Reinhart K; Eichacker PQ
    Anesthesiology; 2003 Jul; 99(1):81-9. PubMed ID: 12826846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats.
    Cui X; Zeni F; Vodovitz Y; Correa-de-Araujo R; Quezado M; Roberts A; Wahl S; Danner RL; Banks SM; Gerstenberger E; Fitz Y; Natanson C; Eichacker PQ
    Cytokine; 2003 Nov; 24(4):115-27. PubMed ID: 14572790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Nesland JM; Giercksky KE
    Crit Care Med; 1996 May; 24(5):820-6. PubMed ID: 8706460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reproduction of a model of "two-hit" sepsis model with complication of pneumonia in rat].
    Chen Y; Li H; Ma S; Deng B; Lu J; Ding F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Oct; 27(10):805-10. PubMed ID: 27132442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant tumor necrosis factor-alpha p80 receptor:Fc fusion protein decreases circulating bioactive tumor necrosis factor-alpha but not lung injury or mortality during immunosuppression-related gram-negative bacteremia.
    Lechner AJ; Johanns CA; Matuschak GM
    J Crit Care; 1997 Mar; 12(1):28-38. PubMed ID: 9075062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the biologic activity of tumor necrosis factor maintains vascular endothelial cell function during hyperdynamic sepsis.
    Wang P; Wood TJ; Zhou M; Ba ZF; Chaudry IH
    J Trauma; 1996 May; 40(5):694-700; discussion 701-1. PubMed ID: 8614066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.
    Peng ZY; Carter MJ; Kellum JA
    Crit Care Med; 2008 May; 36(5):1573-7. PubMed ID: 18434884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.